Contact Me
Menu

The HTMA Copper Toxicity Fallacy

Scroll to top
Scroll to top

This piece was originally published on my Substack on September 17, 2025. If you’d like to follow my writing there, you can find me at mineralshaman.substack.com

The wellness world runs on villains, and for years the villain has been copper toxicity. Hair Tissue Mineral Analysis practitioners have attached it to anxiety, depression, chronic fatigue, brain fog, and most of the rest of the modern symptom list. My argument here is that the narrative rests on a structural problem in how the claim is built, not on the strength of the evidence behind it.

The alternative I want to put forward is that most of what gets attributed to copper toxicity is better explained by iron dysregulation, which has a large and well developed mechanistic literature behind it.

The claim that can’t be wrong

Start with logic rather than biochemistry.

The copper toxicity framework, as it’s commonly applied, works like this. High copper in hair means copper toxicity. Low copper in hair means hidden copper toxicity. Normal copper in hair means hidden copper toxicity, because ratios matter more than levels.

In several years of reviewing HTMA reports as a health coach, I have yet to see a client come out of a consultation with a traditional HTMA practitioner without a copper toxicity finding. High, low, or normal, the conclusion arrives intact.

Karl Popper’s demarcation criterion is the relevant tool here. A theory earns scientific standing partly by what it forbids. If no possible observation could count against it, it isn’t being tested by observation at all, whatever else it might be doing.

Carl Sagan made the same point with his dragon. Someone tells you there’s a fire-breathing dragon in their garage. You go look and see a ladder, some paint cans, an old tricycle, and no dragon. She’s invisible, they explain. You suggest flour on the floor to catch her footprints, and learn that she floats. You propose infrared to find the fire, and learn that the fire gives off no heat. You offer to spray paint her outline, and learn she’s incorporeal. Each test you devise gets a matching exemption. Sagan’s question is what separates a dragon like that from no dragon at all.

Copper toxicity as commonly practiced has the same shape. It can present as high, low, or normal, and there’s an interpretive layer waiting to absorb whichever one you get. Challenge a reading and the response is usually additional structure rather than revision. Calcium shells. Bowl patterns. Oxidation types. Four lows. Ratios that reveal what the levels concealed. If your symptoms don’t fit the expected pattern, the framework says you haven’t looked deeply enough, which is not a claim anyone can check.

Let me hold myself to the same standard, because a piece that invokes Popper and then exempts its own thesis has done nothing. My claim is that iron dysregulation explains most of the symptom picture attributed to copper toxicity. That claim is testable and could fail. If people with these symptoms consistently showed no markers of iron dysregulation, or if lowering iron burden in that population reliably produced nothing, I would be wrong. I’d want to see the ferritin, the transferrin saturation, and the serum iron before drawing conclusions in either direction.

The arithmetic

The body holds roughly 70 to 100 mg of copper and somewhere between 4,000 and 5,000 mg of iron. That’s forty to seventy times more iron than copper.

When the question is which metal is more likely to drive Fenton chemistry, quantity isn’t the whole answer, but it isn’t nothing either. Fe2+ plus hydrogen peroxide yields Fe3+, hydroxyl radical, and hydroxide. That reaction is well characterized and it runs on the more abundant metal.

There’s also a substantial literature on the labile iron pool: the loosely bound, redox-active fraction that participates in lipid peroxidation, ferroptosis, and neurodegeneration. Nothing comparable exists for a pathological labile copper pool. Loosely bound copper in the body appears to be doing signaling work, not damage.

What tissue copper measurements can and can’t tell us

This is worth dwelling on, because it undercuts a lot of the research the copper toxicity paradigm leans on.

A tissue biopsy measures total copper. It cannot distinguish copper safely bound to enzymes and transport proteins, copper sequestered by metallothionein, and copper in some hypothetically free and reactive state. Elevated tissue copper is compatible with excellent enzyme function. Finding a crew on a construction site tells you nothing about whether the building is going up or falling down.

What the reliability data actually shows

The methodological problems with hair analysis have been documented for a long time, and the findings are worse than most practitioners realize.

A German study published in 2002 sent hair samples from two volunteers to seven laboratories offering commercial hair mineral analysis, comparing the 23 elements all seven reported. For the first volunteer, only 6 of those 23 fell within 30 percent of the consensus value. For the second, only 2 did. Differences above 100 percent showed up for most of the rest. Classification into reference ranges was worse still: for the first volunteer, only 3 of 23 elements were placed in the same category by all seven labs.

A 2013 study in Annals of Dermatology sent split samples from one healthy volunteer to three commercial laboratories. The quantitative results were reasonably consistent, but each lab used its own reference ranges, so each one read the same person’s health differently. One concluded he was copper and zinc deficient. Between them, the labs projected chronic fatigue, dizziness, insomnia, depression, and anxiety, and flagged risk for osteomalacia, skin disease, arthralgia, anemia, high cholesterol, alopecia, and myalgia. The donor was fine. His bloodwork, EKG, and chest radiograph were all unremarkable.

Add the known technical constraints. Washing hair in tap water introduces calcium, magnesium, sodium, iron, and copper from the water itself, which makes it difficult to separate internal status from external contamination. Sample preparation destroys information about oxidation state, and oxidation state is much of what determines whether a metal is doing chemistry or sitting still. And hair mineral content has never been shown to track tissue mineral content reliably, which was the original premise.

I should say plainly where this leaves me, since I use these tests myself. I don’t read them the way traditional HTMA does. In the Root Cause Protocol we work primarily with the electrolytes, which give us a usable picture of how someone is handling stress. That’s a narrow question, and it’s one the test can actually answer. For anything else, we go to blood, because blood is where those answers live.

So the reliability data doesn’t put me out of business. It tells me what the tool is for. No single hair result can carry a diagnosis. Comparisons across laboratories are close to meaningless. Anything resting on a small difference between two numbers is resting on noise. Those constraints are real and I’d rather say them out loud.

That’s the actual dividing line here, and it isn’t whether a practitioner uses hair analysis. It’s whether they’ll name what it can’t do. A framework that acknowledges its limits can be corrected. A framework that converts every possible result into the same conclusion cannot.

Iron dysregulation produces the same symptom picture

Fatigue, depression, anxiety, cognitive dysfunction. That list is also the clinical picture of iron accumulation and dysregulation, where iron in tissue drives oxidative stress through the Fenton reaction and produces exactly the neurological and psychiatric presentation attributed to copper.

The relationship between the two metals is the part that gets inverted most often. Copper doesn’t antagonize iron. It regulates it. Ceruloplasmin is a copper-dependent ferroxidase that converts ferrous iron to ferric iron so it can be loaded onto transferrin and moved safely. When copper-dependent systems fail, iron accumulates. Copper insufficiency causes iron problems, not because the two compete, but because iron metabolism runs on copper.

Aceruloplasminemia makes the point about as cleanly as biology allows. It’s caused by mutations affecting ceruloplasmin, and it presents as an iron overload disorder with iron accumulating in the brain. A copper-dependent system fails and the pathology that follows is iron pathology.

Even in Wilson’s disease, a genuine copper accumulation disorder, secondary iron overload has been described, including iron accumulation in the liver during chelation treatment, with reports of liver function improving when iron burden was reduced.

The clinical cost of getting this backwards is real. Someone with iron dysregulation gets told they have copper toxicity, receives an approach that may further impair iron handling, and their actual problem goes unexamined.

Where this leaves us

The copper toxicity paradigm, as commonly practiced, doesn’t forbid any observation. That alone should give a practitioner pause, before anyone gets to the biochemistry.

The biochemistry points elsewhere anyway. We carry forty to seventy times more iron than copper. Iron drives oxidative damage through well documented mechanisms. Copper regulates iron rather than competing with it. And the symptom list blamed on copper excess matches the one produced by iron dysregulation.

None of that makes me certain, and I’ve said what would change my mind. What I’d ask of anyone working in this space is the same thing: name the finding that would count against your framework. If you can’t, the framework isn’t telling you anything about the person in front of you.

References

Popper, K. (1959). The Logic of Scientific Discovery. London: Hutchinson.

Sagan, C. (1995). The Demon-Haunted World: Science as a Candle in the Dark. New York: Random House.

Seidel, S., et al. Assessment of hair mineral analysis commercially offered in Germany. Journal of Trace Elements in Medicine and Biology (2002).

Namkoong, S., et al. Reliability on intra-laboratory and inter-laboratory data of hair mineral analysis comparing with blood analysis. Annals of Dermatology, 25(1), 2013.

Share This Post

More To Explore

The HTMA Copper Toxicity Fallacy

This piece was originally published on my Substack on September 17, 2025. If you’d like to follow my writing there, you can find me at mineralshaman.substack.com

The wellness world runs on villains, and for years the villain has been copper toxicity. Hair Tissue Mineral Analysis practitioners have attached it to anxiety, depression, chronic fatigue, brain fog, and most of the rest of the modern symptom list. My argument here is that the narrative rests on a structural problem in how the claim is built, not on the strength of the evidence behind it.

The alternative I want to put forward is that most of what gets attributed to copper toxicity is better explained by iron dysregulation, which has a large and well developed mechanistic literature behind it.

The claim that can’t be wrong

Start with logic rather than biochemistry.

The copper toxicity framework, as it’s commonly applied, works like this. High copper in hair means copper toxicity. Low copper in hair means hidden copper toxicity. Normal copper in hair means hidden copper toxicity, because ratios matter more than levels.

In several years of reviewing HTMA reports as a health coach, I have yet to see a client come out of a consultation with a traditional HTMA practitioner without a copper toxicity finding. High, low, or normal, the conclusion arrives intact.

Karl Popper’s demarcation criterion is the relevant tool here. A theory earns scientific standing partly by what it forbids. If no possible observation could count against it, it isn’t being tested by observation at all, whatever else it might be doing.

Carl Sagan made the same point with his dragon. Someone tells you there’s a fire-breathing dragon in their garage. You go look and see a ladder, some paint cans, an old tricycle, and no dragon. She’s invisible, they explain. You suggest flour on the floor to catch her footprints, and learn that she floats. You propose infrared to find the fire, and learn that the fire gives off no heat. You offer to spray paint her outline, and learn she’s incorporeal. Each test you devise gets a matching exemption. Sagan’s question is what separates a dragon like that from no dragon at all.

Copper toxicity as commonly practiced has the same shape. It can present as high, low, or normal, and there’s an interpretive layer waiting to absorb whichever one you get. Challenge a reading and the response is usually additional structure rather than revision. Calcium shells. Bowl patterns. Oxidation types. Four lows. Ratios that reveal what the levels concealed. If your symptoms don’t fit the expected pattern, the framework says you haven’t looked deeply enough, which is not a claim anyone can check.

Let me hold myself to the same standard, because a piece that invokes Popper and then exempts its own thesis has done nothing. My claim is that iron dysregulation explains most of the symptom picture attributed to copper toxicity. That claim is testable and could fail. If people with these symptoms consistently showed no markers of iron dysregulation, or if lowering iron burden in that population reliably produced nothing, I would be wrong. I’d want to see the ferritin, the transferrin saturation, and the serum iron before drawing conclusions in either direction.

The arithmetic

The body holds roughly 70 to 100 mg of copper and somewhere between 4,000 and 5,000 mg of iron. That’s forty to seventy times more iron than copper.

When the question is which metal is more likely to drive Fenton chemistry, quantity isn’t the whole answer, but it isn’t nothing either. Fe2+ plus hydrogen peroxide yields Fe3+, hydroxyl radical, and hydroxide. That reaction is well characterized and it runs on the more abundant metal.

There’s also a substantial literature on the labile iron pool: the loosely bound, redox-active fraction that participates in lipid peroxidation, ferroptosis, and neurodegeneration. Nothing comparable exists for a pathological labile copper pool. Loosely bound copper in the body appears to be doing signaling work, not damage.

What tissue copper measurements can and can’t tell us

This is worth dwelling on, because it undercuts a lot of the research the copper toxicity paradigm leans on.

A tissue biopsy measures total copper. It cannot distinguish copper safely bound to enzymes and transport proteins, copper sequestered by metallothionein, and copper in some hypothetically free and reactive state. Elevated tissue copper is compatible with excellent enzyme function. Finding a crew on a construction site tells you nothing about whether the building is going up or falling down.

What the reliability data actually shows

The methodological problems with hair analysis have been documented for a long time, and the findings are worse than most practitioners realize.

A German study published in 2002 sent hair samples from two volunteers to seven laboratories offering commercial hair mineral analysis, comparing the 23 elements all seven reported. For the first volunteer, only 6 of those 23 fell within 30 percent of the consensus value. For the second, only 2 did. Differences above 100 percent showed up for most of the rest. Classification into reference ranges was worse still: for the first volunteer, only 3 of 23 elements were placed in the same category by all seven labs.

A 2013 study in Annals of Dermatology sent split samples from one healthy volunteer to three commercial laboratories. The quantitative results were reasonably consistent, but each lab used its own reference ranges, so each one read the same person’s health differently. One concluded he was copper and zinc deficient. Between them, the labs projected chronic fatigue, dizziness, insomnia, depression, and anxiety, and flagged risk for osteomalacia, skin disease, arthralgia, anemia, high cholesterol, alopecia, and myalgia. The donor was fine. His bloodwork, EKG, and chest radiograph were all unremarkable.

Add the known technical constraints. Washing hair in tap water introduces calcium, magnesium, sodium, iron, and copper from the water itself, which makes it difficult to separate internal status from external contamination. Sample preparation destroys information about oxidation state, and oxidation state is much of what determines whether a metal is doing chemistry or sitting still. And hair mineral content has never been shown to track tissue mineral content reliably, which was the original premise.

I should say plainly where this leaves me, since I use these tests myself. I don’t read them the way traditional HTMA does. In the Root Cause Protocol we work primarily with the electrolytes, which give us a usable picture of how someone is handling stress. That’s a narrow question, and it’s one the test can actually answer. For anything else, we go to blood, because blood is where those answers live.

So the reliability data doesn’t put me out of business. It tells me what the tool is for. No single hair result can carry a diagnosis. Comparisons across laboratories are close to meaningless. Anything resting on a small difference between two numbers is resting on noise. Those constraints are real and I’d rather say them out loud.

That’s the actual dividing line here, and it isn’t whether a practitioner uses hair analysis. It’s whether they’ll name what it can’t do. A framework that acknowledges its limits can be corrected. A framework that converts every possible result into the same conclusion cannot.

Iron dysregulation produces the same symptom picture

Fatigue, depression, anxiety, cognitive dysfunction. That list is also the clinical picture of iron accumulation and dysregulation, where iron in tissue drives oxidative stress through the Fenton reaction and produces exactly the neurological and psychiatric presentation attributed to copper.

The relationship between the two metals is the part that gets inverted most often. Copper doesn’t antagonize iron. It regulates it. Ceruloplasmin is a copper-dependent ferroxidase that converts ferrous iron to ferric iron so it can be loaded onto transferrin and moved safely. When copper-dependent systems fail, iron accumulates. Copper insufficiency causes iron problems, not because the two compete, but because iron metabolism runs on copper.

Aceruloplasminemia makes the point about as cleanly as biology allows. It’s caused by mutations affecting ceruloplasmin, and it presents as an iron overload disorder with iron accumulating in the brain. A copper-dependent system fails and the pathology that follows is iron pathology.

Even in Wilson’s disease, a genuine copper accumulation disorder, secondary iron overload has been described, including iron accumulation in the liver during chelation treatment, with reports of liver function improving when iron burden was reduced.

The clinical cost of getting this backwards is real. Someone with iron dysregulation gets told they have copper toxicity, receives an approach that may further impair iron handling, and their actual problem goes unexamined.

Where this leaves us

The copper toxicity paradigm, as commonly practiced, doesn’t forbid any observation. That alone should give a practitioner pause, before anyone gets to the biochemistry.

The biochemistry points elsewhere anyway. We carry forty to seventy times more iron than copper. Iron drives oxidative damage through well documented mechanisms. Copper regulates iron rather than competing with it. And the symptom list blamed on copper excess matches the one produced by iron dysregulation.

None of that makes me certain, and I’ve said what would change my mind. What I’d ask of anyone working in this space is the same thing: name the finding that would count against your framework. If you can’t, the framework isn’t telling you anything about the person in front of you.

References

Popper, K. (1959). The Logic of Scientific Discovery. London: Hutchinson.

Sagan, C. (1995). The Demon-Haunted World: Science as a Candle in the Dark. New York: Random House.

Seidel, S., et al. Assessment of hair mineral analysis commercially offered in Germany. Journal of Trace Elements in Medicine and Biology (2002).

Namkoong, S., et al. Reliability on intra-laboratory and inter-laboratory data of hair mineral analysis comparing with blood analysis. Annals of Dermatology, 25(1), 2013.

Share This Post

More To Explore

Contact Me